tirzepatide phase 3 Read now: The SURPASS-EARLY trial found that starting #tirzepatide early in #type2diabetes led to greater improvements in blood sugar, body weight, and waist size than intensified standard care. https://bit.ly/3RWnB8m SURMOUNT-3 study design This is

Eli Lilly has not submitted a New Drug Application (NDA) to the FDA

GLP-1 is a naturally occurring peptide that plays a major role in appetite regulation and blood sugar control

Appetite : Reduces hunger and cravings, making it easier to maintain a calorie deficit

Serious but rare complications include pancreatitis and gallbladder issues

Based on previous reports in the literature, hypophosphatemia can be classified into six different forms: adult hypophosphatemia, hypophosphatemia in children, infant hypophosphatemia, perinatal hypophosphatemia, benign prenatal hypophosphatemia, and dental phosphate deficiency

Up to 2540% of total weight lost on current GLP-1s can be lean muscle mass